Dr. Matthew McMahon leads the Small Business Education and Entrepreneurial Development Office (SEED) helping to transform cutting-edge technologies into products that improve health and save lives.

SEED educates and assists NIH-funded innovators as they transition from discovery science to product development. SEED helps academic innovators validate the potential health impacts of their discoveries through a national network of proof-of-concept centers and provides a host of professional advisory services to small business innovators funded by NIH’s $1.2 billion/year SBIR and STTR programs.

Matthew has a diverse background in academia, small business, congressional policy, and NIH program management. He previously served as the first director of the National Heart, Lung, and Blood Institute’s Office of Translational Alliances and Coordination, and he created and led the National Eye Institute’s Office of Translational Research. His previous experience also includes service as the principal scientist for the bionic eye company Second Sight Medical Products and as a staff member on both the United States Senate and House of Representatives committees responsible for science, technology, and innovation policy. Matthew holds a B.S. in Optical Engineering from the University of Rochester and an M.A. and Ph.D. in Experimental Psychology from the University of California, San Diego.